Gerber, LLC
- SEC CIK
- 0002014164
- Latest filing
- Jul 29, 2026
MNPR holding history
Monopar Therapeutics in every 13F filed by Gerber, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MNPR overviewAll 13F holders of MNPRFull Q2 2026 holdings
- Shares (Q2 2026)
- 5,601
- Value
- $518.6K
- % of portfolio
- 0.2%
- Quarters held
- 9
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 5,601 | $518.6K | 0.2% | 00.0% | Unchanged | Holders |
| Q1 2026 | 5,601 | $306.9K | 0.2% | 00.0% | Unchanged | Holders |
| Q4 2025 | 5,601 | $365.7K | 0.2% | 00.0% | Unchanged | Holders |
| Q3 2025 | 5,601 | $457.4K | 0.3% | 00.0% | Unchanged | Holders |
| Q2 2025 | 5,601 | $200.4K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 5,601 | $203.9K | 0.2% | +5,601 | New | Holders |
| Q3 2024 | 0 | $0 | 0.0% | −5,601−100.0% | Sold outConverted for a 1-for-5 split | Holders |
| Q2 2024 | 28,005 | $20.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 28,005 | $19.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 28,005 | $9.53K | <0.1% | – | No prior filing | Holders |